Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
Clinical trial NCT02211755 · COMPLETED
Trial details
- NCT number
- NCT02211755
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-06
- Primary completion
- 2025-08-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.